Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported ...

RANI stock opened at $1.21 on Thursday. The business’s fifty day moving average price is $1.50 and its two-hundred day moving average price is $1.80. The stock has a market capitalization of $69 ...

On March 31 st, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) reported 2024 results. Since the third quarter report, Rani has participated in multiple investor conferences, raised an additional $ ...

March 31, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics ...

Rani Therapeutics Holdings, Inc. (NASDAQ ... According to InvestingPro data, while the company is actively advancing its pipeline, it faces challenges with cash burn and has yet to achieve ...

Talat Imran; Chief Executive Officer, Director; Rani Therapeutics Holdings Inc Svai Sanford; Chief Financial Officer; Rani Therapeutics Holdings Inc Welcome to the Rani fourth-quarter and full-year ...

Rani Therapeutics is a clinical stage biotech ... and highlight the important advancements that Rani has achieved in its pipeline over the past year. Then I will share how we are leveraging ...